126 related articles for article (PubMed ID: 35151213)
21. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
22. Pioglitazone Reduces β Amyloid Levels
Quan Q; Qian Y; Li X; Li M
Front Aging Neurosci; 2019; 11():178. PubMed ID: 31379559
[TBL] [Abstract][Full Text] [Related]
23. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
Ju Y; Tam KY
Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
[TBL] [Abstract][Full Text] [Related]
24. Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer's Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress.
Liang Y; Ye C; Chen Y; Chen Y; Diao S; Huang M
ACS Chem Neurosci; 2021 Jun; 12(11):1894-1904. PubMed ID: 33983710
[TBL] [Abstract][Full Text] [Related]
25. The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer's Disease in APPSwe/PS1dE9 Mice.
He Z; Han S; Zhu H; Hu X; Li X; Hou C; Wu C; Xie Q; Li N; Du X; Ni J; Liu Q
Front Mol Neurosci; 2020; 13():21. PubMed ID: 32210760
[TBL] [Abstract][Full Text] [Related]
26. Activated PPARγ Abrogates Misprocessing of Amyloid Precursor Protein, Tau Missorting and Synaptotoxicity.
Moosecker S; Gomes P; Dioli C; Yu S; Sotiropoulos I; Almeida OFX
Front Cell Neurosci; 2019; 13():239. PubMed ID: 31263400
[TBL] [Abstract][Full Text] [Related]
27. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
[TBL] [Abstract][Full Text] [Related]
28. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
29. Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
Song N; Zhang L; Chen W; Zhu H; Deng W; Han Y; Guo J; Qin C
Biochim Biophys Acta; 2016 Sep; 1862(9):1786-800. PubMed ID: 27240542
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
31. Tauroursodeoxycholic Acid Attenuates Diet-Induced and Age-Related Peripheral Endoplasmic Reticulum Stress and Cerebral Amyloid Pathology in a Mouse Model of Alzheimer's Disease.
Ochiai T; Nagayama T; Matsui K; Amano K; Sano T; Wakabayashi T; Iwatsubo T
J Prev Alzheimers Dis; 2021; 8(4):483-494. PubMed ID: 34585224
[TBL] [Abstract][Full Text] [Related]
32. Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice.
Du J; Sun B; Chen K; Fan L; Wang Z
Biochem Biophys Res Commun; 2009 Jul; 384(3):357-61. PubMed ID: 19422805
[TBL] [Abstract][Full Text] [Related]
33. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
Wang ZJ; Zhao F; Wang CF; Zhang XM; Xiao Y; Zhou F; Wu MN; Zhang J; Qi JS; Yang W
J Alzheimers Dis; 2019; 72(4):1217-1231. PubMed ID: 31683484
[TBL] [Abstract][Full Text] [Related]
34. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Quan Q; Ma X; Li M; Li X; Yuan H
Exp Ther Med; 2024 Jan; 27(1):31. PubMed ID: 38125359
[TBL] [Abstract][Full Text] [Related]
36. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
Zhang J; Hu M; Teng Z; Tang YP; Chen C
J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
[TBL] [Abstract][Full Text] [Related]
37. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1.
Xu QQ; Su ZR; Hu Z; Yang W; Xian YF; Lin ZX
Phytomedicine; 2022 Nov; 106():154441. PubMed ID: 36108371
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
Mandrekar-Colucci S; Karlo JC; Landreth GE
J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
[TBL] [Abstract][Full Text] [Related]
39. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.
Katsouri L; Lim YM; Blondrath K; Eleftheriadou I; Lombardero L; Birch AM; Mirzaei N; Irvine EE; Mazarakis ND; Sastre M
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12292-12297. PubMed ID: 27791018
[TBL] [Abstract][Full Text] [Related]
40. Danggui Buxue decoction ameliorates mitochondrial biogenesis and cognitive deficits through upregulating histone H4 lysine 12 acetylation in APP/PS1 mice.
Chai GS; Gong J; Wu JJ; Ma RK; Zhu J; Jia DD; Zhang YQ; Zhai XR; Sun HX; Nie YJ; Zhao P; Xu YL; Yu HT
J Ethnopharmacol; 2023 Sep; 313():116554. PubMed ID: 37137453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
